Table 1 Participant characteristics, psychiatric diagnoses and psychotropic medication

N

64

53

34

Gender (female (%))

33 (52%)

23 (43%)

15 (44%)

Age (mean (SD))

18.76 (3.82)

19.31 (4.62)

19.97 (5.03)

Full Scale IQ (mean (SD))

111.25 (12.54)

71.38 (14.04)

104.59 (17.322)

Psychiatric diagnoses (N(%))

Simple phobia

9 (17%)

6 (18%)

Agoraphobia

0

4 (12%)

Social phobia

1 (2%)

6 (18%)

Generalized anxiety

13 (25%)

7 (21%)

Attention deficit disorder

23 (44%)

10 (29%)

Mood disorders

5 (9%)

14 (41%)

Psychotic disorders

3 (6%)

0

Oppositional defiant disorder

1 (2%)

1 (3%)

Obsessive–compulsive disorder

2 (4%)

2 (6%)

Others

2 (4%)

1 (3%)

ADOS-2 module 3 (N = 10) (mean)

ADOS-2 total score

11.7

ADOS-2 SA score

8.1

ADOS-2 RRB score

3.6

ADOS-2 module 4 (N = 24) (mean)

ADOS-2 total score

12.37

ADOS-2 SA score

9.29

ADOS-2 RRB score

3.08

ADI-R (N = 21) (mean)

ADI-R domain A

17.76

ADI-R domain B

13.04

ADI-R domain C

5.76

Questionnaires/interviews (mean (SD))

Vineland (socialisation score)

49.96 (4.88)

43.15 (27.30)

31.26 (5.65)

ERSSQ total score

85.56 (15.40)

55.47 (15.92)

49.27 (14.56)

SIAS total score

22.46 (14.49)

31.08 (16.47)

46.80 (16.27)

SCQ total score

2.94 (2.84)

11.25 (6.87)

17.47 (8.13)

Psychotropic medication

Total (N(%))

31 (59%)

11 (33%)

Categories

Psychostimulant

14 (26%)

3 (9%)

Antidepressants

13 (24%)

3 (9%)

Neuroleptics

12 (22%)

3 (9%)

Antiepileptics

3 (6%)

0

Anxiolytics

4 (8%)

2 (6%)